Coral Laboratories Limited (BOM:524506)
India
· Delayed Price · Currency is INR 688.65
+21.50 (3.22%)
At close: Apr 17, 2025
Coral Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Operating Revenue | 1,158 | 836.6 | 781.19 | 756.11 | 965.67 | 705.8 | Upgrade
|
| Revenue | 1,158 | 836.6 | 781.19 | 756.11 | 965.67 | 705.8 | Upgrade
|
| Revenue Growth (YoY) | 74.83% | 7.09% | 3.32% | -21.70% | 36.82% | -22.51% | Upgrade
|
| Cost of Revenue | 516.57 | 381.04 | 467.73 | 408.04 | 521.98 | 417.24 | Upgrade
|
| Gross Profit | 641 | 455.57 | 313.46 | 348.07 | 443.7 | 288.55 | Upgrade
|
| Selling, General & Admin | 151.91 | 121.4 | 112.93 | 117.5 | 125.91 | 110.93 | Upgrade
|
| Other Operating Expenses | 187.61 | 168.3 | 157.99 | 144.69 | 155.13 | 120.43 | Upgrade
|
| Operating Expenses | 359.59 | 309.46 | 292.73 | 282.1 | 300.87 | 251.43 | Upgrade
|
| Operating Income | 281.42 | 146.11 | 20.73 | 65.97 | 142.83 | 37.13 | Upgrade
|
| Interest Expense | -0.59 | -0 | -3.39 | -1.41 | -0.43 | -0.58 | Upgrade
|
| Interest & Investment Income | 33.56 | 33.56 | 17.87 | 17.49 | 20.45 | 17.19 | Upgrade
|
| Currency Exchange Gain (Loss) | 9.51 | 9.51 | 32.35 | 13.83 | 0.01 | 17.17 | Upgrade
|
| Other Non Operating Income (Expenses) | 40.66 | 19.78 | 14.31 | 13.09 | 13.08 | 20.27 | Upgrade
|
| EBT Excluding Unusual Items | 364.55 | 208.96 | 81.88 | 108.96 | 175.94 | 91.17 | Upgrade
|
| Other Unusual Items | -0.91 | -1.64 | 0.38 | 9.59 | 0.19 | - | Upgrade
|
| Pretax Income | 363.64 | 207.32 | 82.26 | 118.56 | 176.12 | 91.17 | Upgrade
|
| Income Tax Expense | 92.48 | 49.43 | 17.81 | 28.1 | 40.58 | 19.87 | Upgrade
|
| Net Income | 271.16 | 157.89 | 64.45 | 90.46 | 135.55 | 71.3 | Upgrade
|
| Net Income to Common | 271.16 | 157.89 | 64.45 | 90.46 | 135.55 | 71.3 | Upgrade
|
| Net Income Growth | 197.65% | 144.97% | -28.75% | -33.27% | 90.10% | -30.21% | Upgrade
|
| Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 | 4 | Upgrade
|
| EPS (Basic) | 75.89 | 44.19 | 18.04 | 25.32 | 37.94 | 19.96 | Upgrade
|
| EPS (Diluted) | 75.89 | 44.19 | 18.04 | 25.32 | 37.94 | 19.96 | Upgrade
|
| EPS Growth | 197.61% | 144.97% | -28.75% | -33.27% | 90.10% | -30.21% | Upgrade
|
| Free Cash Flow | - | -64.56 | 107.2 | 5.35 | -4.29 | -52.43 | Upgrade
|
| Free Cash Flow Per Share | - | -18.07 | 30.01 | 1.50 | -1.20 | -14.68 | Upgrade
|
| Dividend Per Share | - | 2.000 | - | - | - | - | Upgrade
|
| Gross Margin | 55.38% | 54.45% | 40.13% | 46.03% | 45.95% | 40.88% | Upgrade
|
| Operating Margin | 24.31% | 17.46% | 2.65% | 8.72% | 14.79% | 5.26% | Upgrade
|
| Profit Margin | 23.43% | 18.87% | 8.25% | 11.96% | 14.04% | 10.10% | Upgrade
|
| Free Cash Flow Margin | - | -7.72% | 13.72% | 0.71% | -0.45% | -7.43% | Upgrade
|
| EBITDA | 299.62 | 165.82 | 42.45 | 85.75 | 162.48 | 57 | Upgrade
|
| EBITDA Margin | 25.88% | 19.82% | 5.43% | 11.34% | 16.83% | 8.08% | Upgrade
|
| D&A For EBITDA | 18.21 | 19.71 | 21.72 | 19.78 | 19.65 | 19.88 | Upgrade
|
| EBIT | 281.42 | 146.11 | 20.73 | 65.97 | 142.83 | 37.13 | Upgrade
|
| EBIT Margin | 24.31% | 17.46% | 2.65% | 8.72% | 14.79% | 5.26% | Upgrade
|
| Effective Tax Rate | 25.43% | 23.84% | 21.65% | 23.70% | 23.04% | 21.79% | Upgrade
|
| Revenue as Reported | 1,245 | 902.93 | 850.14 | 804.24 | 1,003 | 764.71 | Upgrade
|
| Advertising Expenses | - | 9.41 | 1.6 | 5.24 | 24.09 | 11.38 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.